The Business Cocktail Archives | DelveInsight Business Research

The Business Cocktail

pharma news

Roche, Sarepta collaborates; FDA approval for Merck’s Ervebo, and Allergan’s Ubrelvy

Dec 24, 2019• Business Consultant, Pharma Consultant, pharma consultant, The Business Cocktail

Pharma News

GBT, Syros; Takeda, Cevance collaborates; IND application to ZN-c3

Dec 19, 2019• Articles, Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

Global Therapeutics and Syros Pharmaceuticals have teamed up to move forward to discover, develop and market novel Sickle cell disease and...

pharma news

Wave Life Sciences stocks implode; Amarin’s VASCEPA approval; GSK seeks approval

Dec 17, 2019• Business Consultant, DelveInsight's Drug Report, Pharma Consultant, The Business Cocktail

Wave Life Sciences has recently announced the discontinuation of its drug suvodirsen, for the treatment of a rare Duchenne Muscular...

Pharma News

Omega’s sixth funding round; Correvio’s drug failure; and BIMA acquisition

Dec 12, 2019• Business Consultant, DelveInsight's Oncology based Reports, Notizia, Pharma Consultant, The Business Cocktail

pharma news

Acquisition of ArQule; Synthorx; and Zentalis nabs a raise

Dec 10, 2019• Business Consultant, DelveInsight's Drug Report, Notizia, Oncology based Indications, Pharma Consultant, The Business Cocktail

Merck is set to complete the already planned purchase of the ArQule for USD 2.7 Billion. Under the terms of the agreement, Merck will pay...

Pharma News

Cumberland’s methotrexate product gets approval in the US; Baker Brothers purchases stake in Kodiak’s KSI-301; Sanofi offloads Seprafilm unit to Baxter

Dec 3, 2019• Articles, Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Cumberland Pharmaceuticals has recently received approval from the US FDA for its RediTrex injection for the treatment of rheumatoid...

Pharma News

Toujeo to treat Type 1 Diabetes; TauRx for Alzheimer’s patients

Nov 28, 2019• Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail

Pharma News

Novartis buys Medicines Co. for USD 9.7 Billion

Nov 26, 2019• Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

Novartis plans to buy The Medicines Company for USD 9.7 Billion to gain access to a heart drug inclisiran, almost ready to get into the...

Pharma news

GHO to advance healthcare in Europe; Truvian nets USD 27.1 Mn; Lilly plans its diabetes portfolio expansion

Nov 21, 2019• Business Consultant, DelveInsight's Indication Pipeline Reports, Notizia, Pharma Consultant, The Business Cocktail

Global Healthcare Opportunities (GHO) Capital, a London-based healthcare investment firm, has recently netted USD 1.1 Billion to advance...

Pharma news

Nordisk ties up with Dicerna; Pfizer’s drug gets FDA nod

Nov 19, 2019• Business Consultant, DelveInsight's Drug Report, Notizia, Pharma Consultant, The Business Cocktail